Carboplatin-Gemcitabine Treatment of Patients with Transitional Cell Carcinoma of the Bladder and Impaired Renal Function

Publisher： Karger

E-ISSN： 1423-0232|59|1|24-27

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.1, 2000-06, pp. : 24-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical Gemcitabine in BCG-Refractory T1G3 Transitional Cell Carcinoma of the Bladder: A Pilot Study

By  

Urologia Internationalis, Vol. 76, Iss. 2, 2006-02 ,pp. : 106-111

Karger

Access to resources Recommend Favorite

Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: What Percentage of Patients Qualifies for Bladder Preservation Protocols?

By  

Current Urology, Vol. 1, Iss. 1, 2007-09 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Gemcitabine Monotherapy as Second-Line Treatment in Cisplatin-Refractory Transitional Cell Carcinoma – Prognostic Factors for Response and Improvement of Quality of Life

By  

Oncology Research and Treatment, Vol. 25, Iss. 1, 2002-03 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Efficacy of Adjuvant Gemcitabine-Cisplatin Chemotherapy: A Comparative Study between Locally Advanced Transitional Cell Carcinoma of the Bladder and Upper Urinary Tract

By  

Urologia Internationalis, Vol. 85, Iss. 1, 2010-03 ,pp. : 47-51

Karger

Access to resources Recommend Favorite

Isolated Meningeal Recurrence of Transitional Cell Carcinoma of the Bladder

By  

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-06 ,pp. : 171-175

Karger

Access to resources Recommend Favorite